PMID- 22136834 OWN - NLM STAT- MEDLINE DCOM- 20120206 LR - 20230202 IS - 1532-7361 (Electronic) IS - 0039-6060 (Linking) VI - 150 IP - 6 DP - 2011 Dec TI - Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. PG - 1143-52 LID - 10.1016/j.surg.2011.09.028 [doi] AB - BACKGROUND: Controversy exists regarding the role and extent of operation for patients with multiple endocrine neoplasia type 1 (MEN1) and hypergastrinemia. METHODS: An institutional MEN1 database was reviewed to identify patients with evidence of hypergastrinemia. The relationship of extent of resection to achievement of eugastrinemia was evaluated. RESULTS: Operation was performed in 20 patients with MEN1 and hypergastrinemia with a median follow-up of 71 months. Duodenal gastrinomas were identified in 85% of patients who underwent duodenal evaluation. Nodal metastases were identified in 80%. Patients who underwent anatomic regional lymph node dissection (RLND) had a median of 16 nodes removed, vs 1 in patients who did not undergo a formal regional lymphadenectomy. Eugastrinemia was achieved in 12 patients (60%), and 8 (40%) had persistent hypergastrinemia. Compared with patients with persistent hypergastrinemia, patients rendered eugastrinemic more often underwent duodenal evaluation (11/12 vs 2/8; P = .01) and RLND (11/12 vs 3/8; P = .03); there was no relationship between pancreatic resection and achievement of eugastrinemia (P = .32). CONCLUSION: For patients with MEN1-associated hypergastrinemia selected for operative treatment, a strategy including duodenal evaluation and anatomic regional lymphadenectomy is associated with long-term eugastrinemia. In contrast, the extent of pancreatic resection should be dictated by the extent and distribution of pancreatic neuroendocrine neoplasms, rather than by the presence of hypergastrinemia. CI - Copyright (c) 2011. Published by Mosby, Inc. FAU - Dickson, Paxton V AU - Dickson PV AD - Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4008, USA. FAU - Rich, Thereasa A AU - Rich TA FAU - Xing, Yan AU - Xing Y FAU - Cote, Gilbert J AU - Cote GJ FAU - Wang, Huamin AU - Wang H FAU - Perrier, Nancy D AU - Perrier ND FAU - Evans, Douglas B AU - Evans DB FAU - Lee, Jeffrey E AU - Lee JE FAU - Grubbs, Elizabeth G AU - Grubbs EG LA - eng PT - Evaluation Study PT - Journal Article PL - United States TA - Surgery JT - Surgery JID - 0417347 RN - 0 (Gastrins) SB - IM CIN - Chirurg. 2012 May;83(5):480-1. PMID: 22573248 MH - Abdomen MH - Adult MH - Duodenal Neoplasms/blood/diagnosis/*surgery MH - Female MH - Gastrinoma/blood/*surgery MH - Gastrins/*blood MH - Humans MH - *Lymph Node Excision MH - Male MH - Middle Aged MH - Multiple Endocrine Neoplasia Type 1/blood/*surgery MH - *Pancreatectomy MH - Pancreatic Neoplasms/blood/*surgery MH - Pancreaticoduodenectomy MH - Retrospective Studies MH - Treatment Outcome EDAT- 2011/12/06 06:00 MHDA- 2012/02/07 06:00 CRDT- 2011/12/06 06:00 PHST- 2011/03/02 00:00 [received] PHST- 2011/09/16 00:00 [accepted] PHST- 2011/12/06 06:00 [entrez] PHST- 2011/12/06 06:00 [pubmed] PHST- 2012/02/07 06:00 [medline] AID - S0039-6060(11)00542-3 [pii] AID - 10.1016/j.surg.2011.09.028 [doi] PST - ppublish SO - Surgery. 2011 Dec;150(6):1143-52. doi: 10.1016/j.surg.2011.09.028.